Phio Pharmaceuticals (PHIO) Operating Margin Growth (1y) (2013 - 2019)
Phio Pharmaceuticals (PHIO) Operating Margin Growth (1y) (2013 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | -1,651.00 |
| 10 | Phio Pharmaceuticals | 13.94 Mn | 13.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -48,427.00 |
| Mar 31, 2016 | -1.38 Mn |
| Mar 31, 2015 | -76,815.00 |
| Dec 31, 2014 | -778,867.00 |
| Sep 30, 2014 | -1.16 Mn |
| Jun 30, 2014 | -1.60 Mn |
| Mar 31, 2014 | 1.93 Mn |
| Dec 31, 2013 | -440,276.00 |
| Sep 30, 2013 | 72,435.00 |